10-Aug-2024
Download PDF
Kwality Pharma
We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 for the quarter ended as on 30.06.2024 along with the Auditors limited review reports thereon.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
